(3.238.82.77)
[ij] [ij] [ij] 
Email id
 

Year : 2020, Volume : 13, Issue : 5
First page : ( 327) Last page : ( 333)
Print ISSN : 0974-4169. Online ISSN : 0974-4150. Published online : 2020  15.
Article DOI : 10.5958/0974-4150.2020.00063.2

Study on the Cytotoxic Impacts of Thymol as the Segment of Trachyspermum ammi on Bosom Disease (MCF-7) Cells

Parveen Aamna1,*, Jough Sagar Singh2

1Department of Pharmaceutical Chemistry, University Institute of Pharmacy, CSJM University, Kanpur-208022, Uttar PradeshIndia.

2Department of Pharmacology, Ch. Sughar Singh Group of Institutions, Jaswantnagar, Etawah-206245, Uttar PradeshIndia.

*Corresponding Author E-mail: amanaparveen64608@gmail.com

Received:  21  ,  2020; Accepted:  19  ,  2020.

Abstract

Characteristic phenolic mixtures have hindrance impacts on different malignancies. Thymol is one of these mixes present in a few plant sources, for example, ajowan (Trachyspermum ammi) organic products. In this research, thymol was assessed for its potential cytotoxic movement just as its impact on apoptotic quality articulation in bosom malignant growth cell line. We utilized the GC-MS strategy to distinguish the fundamental oil constituents of ajowan. MCF-7 cells were treated by different groupings of thymol and half greatest inhibitory focus (IC50) was assessed by 3-(4, 5-dimethylthiazol-2-yl)- 2, 5-diphenyltetrazolium bromide test. Moreover, morphological modifications and changes of P21, P53 and Mcl-1 quality articulation in MCF-7 cells were explored by infinitesimal assessment and ongoing RT-PCR measure. Information from MTT measure demonstrated that the IC50 estimations of thymol on MCF-7 cells for 48 h and 72 h were 54 and 62 μg/mL, separately. Moreover, this compound essentially influenced quality articulations of P53 and P21, however not Mcl-1. Thymol can actuate the apoptosis procedure in MCF-7, and henceforth it very well may be viewed as an anticancer specialist later on.

Top

Keywords

Thymol, Malignancies, P53, P21, MCF-7.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
812,847,594 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.